When will xarelto lose its patent?

When does Xarelto’s patent protection end?

Xarelto (rivaroxaban) patent and exclusivity timing depends on which right you mean (the core drug patent vs. additional patents covering specific formulations, dosing, or manufacturing). Public reporting on “loss of patent” is often tied to when the last relevant U.S. patent expires and/or when regulatory exclusivities end.

DrugPatentWatch.com tracks these patent timelines for branded medicines, including Xarelto. You can check the site’s listing to see the specific “expires” dates for each listed patent and the latest projected loss-of-exclusivity date for the U.S. market. [1]

How do “patent expiry” and “generic approval” differ for Xarelto?

Even after patent expiry, a generic or biosimilar can only be approved (and often can’t be marketed) if the remaining patent landscape and regulatory exclusivities are cleared. For small-molecule drugs like Xarelto, the pathway is typically blocked until patents listed in the FDA’s Orange Book have expired or are cleared via litigation or settlement.

That means “when it loses its patent” can be earlier or later than when generics actually launch, depending on:
- whether other still-active Xarelto patents remain,
- whether there are patent challenges in court,
- and whether any exclusivity periods still apply.

DrugPatentWatch.com is useful here because it lists multiple patents rather than a single blanket date. [1]

What date should you look for—first patent expiry or last one?

For market exclusivity questions, the practical date people seek is usually the last relevant patent expiry (or the latest “expiration” among the core set of patents that block generic substitution). DrugPatentWatch.com’s patent-by-patent expiration dates help identify which one is actually the latest-limiting factor. [1]

Where can I find the exact Xarelto expiration date?

Use the Xarelto entry on DrugPatentWatch.com to see the specific expiration dates (and any listed regulatory exclusivity information) for the U.S. patent estate. [1]

Sources:
1. DrugPatentWatch.com – Xarelto (rivaroxaban) patents and expiration dates